These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12410498)

  • 1. The third strike.
    Brinker JA
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):284-5. PubMed ID: 12410498
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
    Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK
    Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
    Lepor NE
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease.
    Shavit L; Korenfeld R; Lifschitz M; Butnaru A; Slotki I
    J Interv Cardiol; 2009 Dec; 22(6):556-63. PubMed ID: 19732281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.
    Walker PD; Brokering KL; Theobald JC
    Pharmacotherapy; 2003 Dec; 23(12):1617-26. PubMed ID: 14695041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?
    Billinger M; Hess OM; Meier B
    Eur Heart J; 2004 Feb; 25(3):188-9. PubMed ID: 14972417
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy.
    Bouzas-Mosquera A; Recio-Mayoral A
    Am Heart J; 2008 Apr; 155(4):e31. PubMed ID: 18371455
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast nephropathy after coronary angiography.
    Gami AS; Garovic VD
    Mayo Clin Proc; 2004 Feb; 79(2):211-9. PubMed ID: 14959916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-induced nephropathy remains a serious complication of PCI.
    Mehran R
    J Interv Cardiol; 2007 Jun; 20(3):236-40. PubMed ID: 17524117
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast agent nephropathy.
    Nicol P; Axelson C
    Eur Heart J; 2004 Aug; 25(15):1369; discussion 1369-70. PubMed ID: 15288173
    [No Abstract]   [Full Text] [Related]  

  • 11. N-acetylcysteine and/or theophylline as a preventive measure for contrast agent induced nephropathy: we should use better markers for detection of renal function.
    Schultz MJ
    Radiology; 2007 Dec; 245(3):918-9; author reply 918-9. PubMed ID: 18024462
    [No Abstract]   [Full Text] [Related]  

  • 12. In search of an algorithm to prevent acute kidney injury.
    Dauerman HL
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
    Ng TM; Shurmur SW; Silver M; Nissen LR; O'Leary EL; Rigmaiden RS; Cieciorka M; Porter LL; Ineck BA; Kline ME; Puumala SE
    Int J Cardiol; 2006 May; 109(3):322-8. PubMed ID: 16039733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency?
    Ma IW; Hladunewich M
    CMAJ; 2004 Apr; 170(8):1231. PubMed ID: 15078844
    [No Abstract]   [Full Text] [Related]  

  • 15. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
    Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
    Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
    Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
    Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine somewhere between Scylla and Charybdis.
    Sochman J
    J Am Coll Cardiol; 2010 Sep; 56(13):1067; author reply 1067-8. PubMed ID: 20846610
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contrast-induced nephropathy].
    Westenfeld R; Rump LC
    Dtsch Med Wochenschr; 2013 Apr; 138(14):715-8. PubMed ID: 23533037
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
    Safirstein R; Andrade L; Vieira JM
    N Engl J Med; 2000 Jul; 343(3):210-2. PubMed ID: 10900284
    [No Abstract]   [Full Text] [Related]  

  • 20. N-acetylcysteine and other preventive measures for contrast-induced nephropathy in the intensive care unit.
    Schultz MJ; Baas MC; van der Sluijs HP; Stamkot GA; Smit W
    Curr Med Chem; 2006; 13(21):2565-70. PubMed ID: 17017911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.